AI
STIM icon

AdvisorShares Investments’s Neuronetics STIM Stock Holding History

AdvisorShares Investments’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$966K Buy
742,795
+125,602
+20% +$183K 0.12% 92
2026
Q1 		$895K Buy
617,193
+346,277
+128% +$549K 0.16% 91
2025
Q4 		$374K Buy
270,916
+80,801
+43% +$169K 0.06% 203
2025
Q3 		$519K Buy
190,115
+59,581
+46% +$212K 0.08% 125
2025
Q2 		$456K Buy
130,534
+10,000
+8% +$39.5K 0.08% 174
2025
Q1 		$456K Buy
120,534
+109,360
+979% +$399K 0.09% 131
2024
Q4 		$18K Buy
+11,174
New +$11.6K ﹤0.01% 257

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

AdvisorShares Investments's STIM Position: Q2 2026 in Review

AdvisorShares Investments increased its Neuronetics (STIM) stake by 20% in Q2 2026, buying an estimated $183K and bringing the position to 742,795 shares worth $966K. The position accounts for 0.12% of the portfolio, ranked #92.

AdvisorShares Investments first reported a position in STIM in Q4 2024 and has held it in 7 quarters since. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • AdvisorShares Investments held 742,795 shares of Neuronetics worth $966K as of Q2 2026.
  • AdvisorShares Investments bought 125,602 Neuronetics shares in Q2 2026, an estimated $183K.
  • Neuronetics made up 0.12% of AdvisorShares Investments's portfolio in Q2 2026, its #92 holding.
  • AdvisorShares Investments first reported a position in Neuronetics in Q4 2024 and has held it in 7 quarters since.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.